The Respiratory Disease market within the context of Pulmonary Medicine is a broad field of study that focuses on the diagnosis, treatment, and prevention of diseases that affect the lungs and airways. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, and pulmonary hypertension. Treatment options for these conditions range from lifestyle modifications to medications, and in some cases, surgery. Research in this field is ongoing, with the aim of improving the quality of life for those affected by respiratory diseases. Companies in the Respiratory Disease market include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, and Pfizer. These companies are involved in the development of new treatments and therapies for respiratory diseases, as well as the manufacture and distribution of existing treatments. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
